Aldos as modifiers of the igf pathway and methods of use

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 9/88 (2006.01) C07H 21/04 (2006.01)

Patent

CA 2569046

Human ALDO genes are identified as modulators of the IGF pathway, and thus are therapeutic targets for disorders associated with defective IGF function. Methods for identifying modulators of IGF, comprising screening for agents that modulate the activity of ALDO are provided.

L'invention concerne des gènes ALDO humains qui ont été identifiés comme modulateurs de la voie de signalisation IGF et qui constituent par conséquent des cibles thérapeutiques pour des troubles associés à une fonction IGF déficiente. L'invention porte sur des procédés d'identification de modulateurs de l'IGF, qui consistent à cribler des agents modulant l'activité des gènes ALDO.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aldos as modifiers of the igf pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aldos as modifiers of the igf pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldos as modifiers of the igf pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1406112

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.